Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.

Antioxidants (Basel) · 2024 · PMC11118047 · PMID 38790714

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Initially, unaffected women with blood zinc levels > 5797 μg/L exhibited a twofold reduction in the risk of ovarian cancer compared to women with blood zinc levels ≤ 5797 (HR = 0.51 95% CI: 0.24–1.09), although this did not reach statistical significance ( p = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.